First FDA approved treatment for thyroid eye disease
The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults with thyroid…
News
Making diabetes education more effective
Is individual or group education most effective for patients with diabetes? (more…)
Alcohol-related mortality rates on the rise
A new study published in Alcoholism Clinical & Experimental Research reveals that the amount of alcohol-related deaths in the United States has increased between…
Tokyo restaurant staffed by servers with dementia a success
An innovative restaurant in Tokyo staffed by servers who have dementia reports 99% satisfaction among diners even though mistakes in orders occurred about 37%…
FDA to host meeting on the development of products for rare diseases
On February 24, the U.S. Food and Drug Administration (FDA) is hosting a public meeting to celebrate FDA Rare Disease Day 2020 which will…
Study fails to show benefit of adding vitamin C to treatment of septic shock
A study recently published in the Journal of the American Medial Association aimed to examine if a treatment combination of vitamin C, hydrocortisone, and…
First coronavirus patient identified in U.S.
On the heels of today’s earlier post regarding the increase mortality rates in Wuhan, China from the coronavirus, The New York Times (NYT) just released an article…
Deaths from coronavirus rise
In the past 24 hours, news coverage of the coronavirus in Wuhan, China has become more and more rampant. I first heard of the…
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to 2017 in…
The Parkinson’s Foundation launched first-ever Nurse Fellowship program
The Parkinson’s Foundation recently announced the launch of its new Parkinson’s Nurse Fellowship program in the U.S. (more…)
First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment of adult patients with…
First FDA-approved treatment for preventing Ebola virus
In late December 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Merck’s Ervebo, the first FDA-approved vaccine to prevent Ebola…
First FDA approved treatment for thyroid eye disease
The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults…
Making diabetes education more effective
Is individual or group education most effective for patients with diabetes? (more…)
Alcohol-related mortality rates on the rise
A new study published in Alcoholism Clinical & Experimental Research reveals that the amount of alcohol-related deaths in the United States has…
Tokyo restaurant staffed by servers with dementia a success
An innovative restaurant in Tokyo staffed by servers who have dementia reports 99% satisfaction among diners even though mistakes in orders occurred…
FDA to host meeting on the development of products for rare diseases
On February 24, the U.S. Food and Drug Administration (FDA) is hosting a public meeting to celebrate FDA Rare Disease Day 2020…
Study fails to show benefit of adding vitamin C to treatment of septic shock
A study recently published in the Journal of the American Medial Association aimed to examine if a treatment combination of vitamin C,…
First coronavirus patient identified in U.S.
On the heels of today’s earlier post regarding the increase mortality rates in Wuhan, China from the coronavirus, The New York Times (NYT) just…
Deaths from coronavirus rise
In the past 24 hours, news coverage of the coronavirus in Wuhan, China has become more and more rampant. I first heard…
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to…
The Parkinson’s Foundation launched first-ever Nurse Fellowship program
The Parkinson’s Foundation recently announced the launch of its new Parkinson’s Nurse Fellowship program in the U.S. (more…)
First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment of adult…
First FDA-approved treatment for preventing Ebola virus
In late December 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Merck’s Ervebo, the first FDA-approved vaccine to…
Test Your Knowledge
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.